QIAGEN N.V. Marketable Securities, Gain (Loss)
QIAGEN N.V. (QGEN) reported Marketable Securities, Gain (Loss) of $0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-11.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2024-03-11
| Period end | Marketable Securities, Gain (Loss) 12 month |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-03-11 |
| 2022-12-31 | -$6.23M 20-F · filed 2024-03-11 |
| 2021-12-31 | -$6.55M 20-F · filed 2024-03-11 |
| 2020-12-31 | $1.99M 20-F · filed 2023-03-13 |
| 2019-12-31 | -$2.87M 20-F · filed 2022-03-14 |
| 2018-12-31 | $2.73M 20-F · filed 2021-03-05 |
| 2017-12-31 | -$1.05M 20-F · filed 2020-03-02 |
| 2016-12-31 | $1.36M 20-F · filed 2019-03-06 |
| 2015-12-31 | -$6.04M 20-F · filed 2018-03-06 |
| 2014-12-31 | -$3.91M 20-F · filed 2017-03-06 |
| 2013-12-31 | $0.00 20-F · filed 2016-02-29 |